GSK to donate research fund to academic society of hepatitis.

Published: 2004-03-12 06:57:00

Updated: 2004-03-12 06:57:00

President Kim Jin-ho of GSK delivered the total 140 million won of research fund to the Korea Society of Liver (President: Dr. Seo Dong-jin) on March 9. GSK has developed a therapeutic agent for the B hepatitis viral infection for the first time over the world and donated such scholarship to the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK